SGLT2i

#NephMadness 2020: SGLT2i Region

March 13, 2020 // 2 Comments

Submit your picks! | NephMadness 2020 | #NephMadness | #SGLT2iRegion Selection Committee Member: Meg Jardine @jardine_meg Meg Jardine is Program Head of Innovation & Kidney Research at The George Institute, Head of Renal Trials at George [read more...]

Sweet Pee: Do SGLT2 Inhibitors Prevent and/or Slow the Progression of Diabetic Kidney Disease?

August 15, 2018 // 1 Comment

During NephMadness 2017, the newcomer ‘SGLT2 inhibitors’ team for the Diabetic Nephropathy region surprised the competition and made it all the way to the Filtered Four where it was knocked out by the eventual winner Genes in ESKD Disparity. In [read more...]

#NephMadness 2017: Diabetic Nephropathy Region

March 7, 2017 // 1 Comment

Submit your picks | NephMadness 2017 | #NephMadness or #DNRegion Selection Committee Member for the Diabetic Nephropathy Region: Anna Burgner Dr. Burgner, MD, MEHP, is an assistant professor in nephrology at Vanderbilt University Medical Center [read more...]

AJKD Blog

Official Blog of the American Journal of Kidney Diseases

SGLT2i

#NephMadness 2020: SGLT2i Region

Sweet Pee: Do SGLT2 Inhibitors Prevent and/or Slow the Progression of Diabetic Kidney Disease?

#NephMadness 2017: Diabetic Nephropathy Region